Pulmonary hypertension and right ventricular dysfunction as predictors of severe coronavirus infection

• Published in: Rossiĭskiĭ kardiologicheskiĭ zhurnal Vol. 28; no. 7; p. 5481
• Main Authors: Podzolkov, V. I., Ishina, T. I., Medvedev, I. D., Vetluzhskaya, M. V., Dragomiretskaya, N. A., Yasneva, A. S.
• Format: Journal Article
• Language: English
• Published: FIRMA «SILICEA» LLC 01-08-2023
• Subjects: covid-19; pulmonary hypertension; right ventricular dysfunction; sars-cov-2
• ISSN: 1560-4071; 2618-7620
• DOI: 10.15829/1560-4071-2023-5481

Coronavirus disease 2019 (COVID-19) is a disease characterized by diverse clinical manifestations, the severity of which can vary from asymptomatic to extremely severe. At this stage, the urgent task is the early detection of reliable markers of its severity in the acute period of infection and possible changes that cause symptoms in the post-COVID period. The severe COVID-19 is associated with extensive damage to the lungs, pulmonary vessels, and cardiovascular system. In this regard, it seems natural to study the problem of pulmonary hypertension (PH) and right ventricular dysfunction (RVD) in patients with COVID-19, and their significance for assessing the severity of the condition and prognosis. Also important is the availability of reliable non-invasive diagnostics. This review presents data on the incidence of PH and RVD and their potential significance in patients with COVID-19. We have analyzed literature sources in the eLIBRARY, PubMed/MEDLINE, ScienceDirect and ProQuest databases.